Upper urinary tract urothelial carcinomas (UUT-UCs) are relatively rare tumours that present a challenge to urologists, both in terms of diagnosis and treatment. The diagnostic pathway is often complex and the surgical options continue to generate controversy. The outcomes of treatment are mixed, with invasive tumours having a particularly poor prognosis. In this article we compare UK practice with the most recent European Association of Urology (EAU) guidelines for the management of UUT-UCs.
NCIN. Bladder cancer incidence, mortality and survival rates in the United Kingdom. London: Public Health England, 2013.
2.
NCIN. Renal pelvis and ureter cancer incidence, mortality and survival rates in the United Kingdom. London: Public Health England, 2013.
3.
RouprêtMBabjukMBöhleAet al. Urothelial carcinomas of the upper urinary tract. Arnham: European Association of Urology, 2015.
4.
BabjukMOosterlinckWSylvesterRet al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol2011; 59: 997–1008.
5.
MargulisVShariatSFMatinSFet al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer2009; 115: 1224–1233.
6.
StewartGDBariolSVGrigorKMet al. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int2005; 95: 791–793.
7.
CosentinoMPalouJGayaJMet al. Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma. World J Urol2013; 31: 141–145.
8.
XylinasERinkMMargulisVet al. Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol2012; 61: 1069–1070.
9.
ZigeunerREHuttererGChromeckiTet al. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int2006; 98: 1181–1186.
10.
NovaraGDe MarcoVDalpiazOet al. Independent predictors of metachronous bladder transitional cell carcinoma (UC) after nephroureterectomy for UC of the upper urinary tract. BJU Int2008; 101: 1368–1374.
11.
LiWMShenJTLiCCet al. Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma. Eur Urol2010; 57: 963–969.
12.
NovaraGDe MarcoVDalpiazOet al. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers. Int J Urol2009; 16: 187–191.
13.
CowanNC. CT urography for hematuria. Nat Rev Urol2012; 9: 218–226.
14.
TakahashiNGlocknerJFHartmanRPet al. Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol2010; 183: 1330–1365.
15.
WitjesJARedortaJPJacqminDet al. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations. Eur Urol2010; 57: 607–614.
16.
MesserJShariatSFBrienJCet al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int2011; 108: 701–705.
O’BrienTRayESinghRet al. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C trial). Eur Urol2011; 60: 703–710.
19.
HallMCWomackSSagalowskyAet al. Prognostic factors, recurrence and survival in transitional cell carcinoma of the upper urinary tract, a 30-year experience in 252 patients. Urology1998; 52: 594–601.
20.
HellenthalNJShariatSFMargulisVet al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. J Urol2009; 182: 900–906.
21.
VassilakopoulouMde la Motte RougeTColinPet al. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study. Cancer2011; 117: 5500–5508.
22.
LeowJJMartin-DoyleWFayAPet al. A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma. Eur Urol2014; 66: 529–541.
23.
BirtleAJLewisRJohnsonMet al. Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (UC) - opening of the Peri-Operative Chemotherapy Versus Surveillance in Upper Tract Urothelial Cancer (POUT) Trial. BJU Int2012; 110: 919–921.
24.
AbouassalyRAlibhaiSMShahNet al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology2010; 76: 895–901.
25.
JeldresCSunMIsbarnHet al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology2010; 75: 315–320.
